Mystical experience occasioned by non-medicinal embodied therapy And integration process for mental well-Being
December 22, 2022 Bruce W. Meleski
Expansion of psychoactive hallucinogens in mental health continues to be a major trend. Several psychoactive molecules including psilocybin and MDMA continue to move through the FDA approval process with clinical trials.1 In the meantime, off-label ketamine medically supervised programs and indigenous plant ceremonies continue to expand.2,3 This study explores the potential benefits of High...